{
    "root": "2e524986-7903-416f-b2b8-d27295103e75",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Doxazosin mesylate",
    "value": "20240311",
    "ingredients": [
        {
            "name": "DOXAZOSIN MESYLATE",
            "code": "86P6PQK0MU"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        }
    ],
    "indications": "doxazosin alpha 1 adrenergic antagonist indicated : • signs symptoms benign prostatic hyperplasia ( bph ) ( 1.1 ) • treatment hypertension ( 1.2 )",
    "contraindications": "• treatment bph : initiate therapy 1 mg daily . dose may titrated 1 2-week intervals , 8 mg daily . ( 2.2 ) • treatment hypertension : initiate therapy 1 mg daily . dose may titrated needed , 16 mg daily . ( 2.3 )",
    "warningsAndPrecautions": "doxazosin available tablets oral . tablet contains doxazosin mesylate equivalent 1 mg ( white ) , 2 mg ( white ) , 4 mg ( white ) 8 mg ( white ) doxazosin free base . ndc pack size strength description ndc 59762-1388-7 ( bottle 100 ) 1 mg white , round tablets “ cn1 ” one side “ vle ” side . ndc 59762-1389-7 ( bottle 100 ) 2 mg white , oblong tablets score “ cn 2 ” one side “ vle ” side . ndc 59762-1390-7 ( bottle 100 ) 4 mg white , rhombus shaped tablets break score “ cn 4 ” one side vle side . ndc 59762-1391-7 ( bottle 100 ) 8 mg white , capsule shaped tablets break score “ cn 8 ” one side “ vle ” side . recommended storage : store 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "doxazosin tablet contraindicated patients hypersensitivity doxazosin , quinazolines ( e.g . , prazosin , terazosin ) , components .",
    "indications_original": "Doxazosin is an alpha 1 adrenergic antagonist indicated for: • Signs and symptoms of Benign Prostatic Hyperplasia (BPH) ( 1.1 ) • Treatment of Hypertension ( 1.2 )",
    "contraindications_original": "• For the treatment of BPH: Initiate therapy at 1 mg once daily. Dose may be titrated at 1 to 2-week intervals, up to 8 mg once daily. ( 2.2 ) • For the treatment of hypertension: Initiate therapy at 1 mg once daily. Dose may be titrated as needed, up to 16 mg once daily. ( 2.3 )",
    "warningsAndPrecautions_original": "Doxazosin is available as tablets for oral administration. Each tablet contains Doxazosin mesylate equivalent to 1 mg (white), 2 mg (white), 4 mg (white) or 8 mg (white) of doxazosin as the free base.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              NDC and Pack Size\n                           \n                           \n                              Strength\n                           \n                           \n                              Description\n                           \n                        \n                        \n                           \n                              NDC 59762-1388-7 (Bottle of 100)\n                           \n                           \n                              1 mg\n                           \n                           \n                              White, round tablets with “CN1” on one side and “VLE” on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1389-7 (Bottle of 100)\n                           \n                           \n                              2 mg\n                           \n                           \n                              White, oblong tablets with score and “CN 2” on one side and “VLE” on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1390-7 (Bottle of 100)\n                           \n                           \n                              4 mg\n                           \n                           \n                              White, rhombus shaped tablets with break score and “CN 4” on one side and VLE on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1391-7 (Bottle of 100)\n                           \n                           \n                              8 mg\n                           \n                           \n                              White, capsule shaped tablets with break score and “CN 8” on one side and “VLE” on the other side.\n                           \n                        \n                     \n                  \n                  Recommended Storage: Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "The use of Doxazosin tablet is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components."
}